EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2023 May 24

PMID 37223216

Authors

Xuping Niu

Xinhua Li

Zhipeng Feng

Qixin Han

Juan Li

Yanmin Liu

Kaiming Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Angiogenesis is one of the histologically predominant characteristics of psoriasis. Vascular endothelial growth factor (VEGF) and epidermal growth factor-like repeats and discoidin I-like domains 3 (EDIL3) have critical effects on angiogenesis. Both these proteins are vital proangiogenic factors in tumor occurrence and progression; however, the relationship between EDIL3 and VEGF with psoriasis remains unclear.

Objective: We aimed to elucidate the role of EDIL3 and VEGF and the involved mechanisms in psoriasis-associated angiogenesis.

Methods: EDIL3 and VEGF expression in cutaneous tissue was determined by immunohistochemical assay. The effects of EDIL3 on VEGF, VEGFR2, and the growth, migration, and tube formation of human umbilical vein endothelial cells (HUVECs) were analyzed by Western blotting assay, cell counting kit-8 assay, Transwell assay, and Matrigel tube formation assay.

Results: EDIL3 and VEGF levels in psoriatic lesions significantly increased as compared to those in normal individuals and showed a positive relationship with the Psoriasis Area and Severity Index. The downregulation of EDIL3 decreased VEGF and VEGFR2 expression in HUVECs. Moreover, the decreased expression of EDIL3 and VEGF reduced the growth, invasion, and tube formation abilities of HUVECs, while EDIL3 resistance to VEGF and VEGFR2 was restored by using the EDIL3 recombinant protein.

Conclusion: These results suggest that psoriasis is also characterized by EDIL3 and VEGF-mediated angiogenesis. Thus, EDIL3 and VEGF could serve as novel targets for treating psoriasis.

Citing Articles

HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K.

Xu J, Zou Z, Liu W, Zhang Q, Shen J, Hao F Eur J Neurol. 2024; 31(12):e16473.

PMID: 39315749 PMC: 11555006. DOI: 10.1111/ene.16473.

Developmental endothelial locus 1: the present and future of an endogenous factor in vessels.

Jiang D, Yue H, Liang W, Wu Z Front Physiol. 2024; 15:1347888.

PMID: 39206385 PMC: 11350114. DOI: 10.3389/fphys.2024.1347888.

Methylome analysis of endothelial cells suggests new insights on sporadic brain arteriovenous malformation.

Scimone C, Donato L, Alibrandi S, Conti A, Bortolotti C, Germano A Heliyon. 2024; 10(15):e35126.

PMID: 39170526 PMC: 11336478. DOI: 10.1016/j.heliyon.2024.e35126.

Nischarin inhibits the epithelial-mesenchymal transition process and angiogenesis in breast cancer cells by inactivating FAK/ERK signaling pathway via EGF like repeats and discoidin domains 3.

Zheng R, He Y, Yang L, Chen Y, Wang R, Xie S Mol Biol Rep. 2024; 51(1):821.

PMID: 39023636 DOI: 10.1007/s11033-024-09776-z.

Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.

Marani M, Madan V, Le T, Deng J, Lee K, Ma E Genes (Basel). 2024; 15(2).

PMID: 38397136 PMC: 10887737. DOI: 10.3390/genes15020146.

References

Patel A, Tsilioni I, Weng Z, Theoharides T . TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. Exp Dermatol. 2017; 27(2):135-143. DOI: 10.1111/exd.13461. View

Fan Y, Zhu W, Yang M, Zhu Y, Shen F, Hao Q . Del-1 gene transfer induces cerebral angiogenesis in mice. Brain Res. 2008; 1219:1-7. PMC: 2553757. DOI: 10.1016/j.brainres.2008.05.003. View

Kuang Y, Lu Y, Liu Y, Liao L, Zhou X, Qin Q . Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes. Eur J Pharmacol. 2018; 824:57-63. DOI: 10.1016/j.ejphar.2018.01.048. View

Ameln A, Cremer S, Hoffmann J, Schuster P, Khedr S, Korovina I . Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation. Thromb Haemost. 2017; 117(6):1150-1163. PMC: 5502105. DOI: 10.1160/TH16-05-0354. View

Creamer D, Allen M, Sousa A, Poston R, Barker J . Altered vascular endothelium integrin expression in psoriasis. Am J Pathol. 1995; 147(6):1661-7. PMC: 1869965. View

Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T . Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest. 2003; 112(1):30-41. PMC: 162283. DOI: 10.1172/JCI17034. View

Creamer D, Sullivan D, Bicknell R, Barker J . Angiogenesis in psoriasis. Angiogenesis. 2003; 5(4):231-6. DOI: 10.1023/a:1024515517623. View

Kun Z, Xin G, Tao W, Chenglong Z, Dongsheng W, Liang T . Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model. J Bone Oncol. 2019; 16:100238. PMC: 6512748. DOI: 10.1016/j.jbo.2019.100238. View

Schurpf T, Chen Q, Liu J, Wang R, Springer T, Wang J . The RGD finger of Del-1 is a unique structural feature critical for integrin binding. FASEB J. 2012; 26(8):3412-20. PMC: 3405271. DOI: 10.1096/fj.11-202036. View

10.

Akhtar T, Wani W, Kamal M, Kaur R . Role of Angiogenic Growth Factors in Psoriasis: A Review. Curr Drug Metab. 2018; 19(11):910-916. DOI: 10.2174/1389200219666180416162942. View

11.

Niu X, Chang W, Liu R, Hou R, Li J, Wang C . mRNA and protein expression of the angiogenesis-related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis. Clin Exp Dermatol. 2015; 41(5):533-40. DOI: 10.1111/ced.12783. View

12.

Yan S, Chen L, Zhao Q, Liu Y, Hou R, Yu J . Developmental endothelial locus-1 (Del-1) antagonizes Interleukin-17-mediated allergic asthma. Immunol Cell Biol. 2018; 96(5):526-535. DOI: 10.1111/imcb.12023. View

13.

Chung S, Bae S, Lee M, Al-Hilal T, Lee C, Kim J . LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways. Biomaterials. 2014; 37:271-8. DOI: 10.1016/j.biomaterials.2014.10.004. View

14.

Macdonald A, Burden A . Psoriasis: advances in pathophysiology and management. Postgrad Med J. 2007; 83(985):690-7. PMC: 2659962. DOI: 10.1136/pgmj.2007.061473. View

15.

Li T, Gu M, Liu P, Liu Y, Guo J, Zhang W . Clinical Significance of Decreased Interleukin-35 Expression in Patients with Psoriasis. Microbiol Immunol. 2018; . DOI: 10.1111/1348-0421.12605. View

16.

A R, Yu P, Hao S, Li Y . MiR-876-5p suppresses cell proliferation by targeting Angiopoietin-1 in the psoriasis. Biomed Pharmacother. 2018; 103:1163-1169. DOI: 10.1016/j.biopha.2018.04.145. View

17.

Lebwohl M . Psoriasis. Ann Intern Med. 2018; 168(7):ITC49-ITC64. DOI: 10.7326/AITC201804030. View

18.

Schroder K . Redox Control of Angiogenesis. Antioxid Redox Signal. 2018; 30(7):960-971. DOI: 10.1089/ars.2017.7429. View

19.

Lee J, Jeong J, Jung J, Kim W, Lee S, Park J . Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer. Oncology. 2019; 97(3):180-188. DOI: 10.1159/000501340. View

20.

Mousavi S, Skjeldal F, Fonhus M, Haugen L, Eskild W, Berg T . Receptor-Mediated Endocytosis of VEGF-A in Rat Liver Sinusoidal Endothelial Cells. Biomed Res Int. 2019; 2019:5496197. PMC: 6754870. DOI: 10.1155/2019/5496197. View